Electronic Screen for Counterfeit Rxs in Pharmacies
Citing an "immediate danger ofcounterfeit medicines entering the USsupply chain,"representatives of thenation's pharmaceutical manufacturerscalled on the nation's pharmacies toemploy "electronic authenticationtechnologies"to protect the publicagainst fake drugs.
In a new "White Paper"issued bythe Pharmaceutical Research and Manufacturersof America (PhRMA), drugmakersspecifically endorsed the use of"2-dimensional bar codes and radiofrequency identification [RFID] tags tosecure the US drug supply againstcounterfeit threats."
More than a year ago, the FDA hadendorsed an electronic solution to thecounterfeit drug problem, noting thatthe use of RFID technology to establishan "electronic pedigree"for medicationswould represent the "single mostpowerful tool available to secure theUS drug supply."
PhRMA, however, had argued thatthe creation of an electronic pedigreesystem able to track the distribution ofdrugs from manufacturer to patient "islikely to be complex and not fullyachievable for 5 or more years."In theinterim, the association urged governmentand industry to "make progress inadopting electronic mechanisms thatwill permit the real-time authenticationof prescription pharmaceutical packagingdirectly at the dispensing level."
Authentication of drug products atthe pharmacy level can have an"immediate and lasting impact onpatient safety."Authentication can beaccomplished over the short term byusing "mass serialization and availableelectronic technology, such as bar codingor RFID tags,"PhRMA officials said.
Mr. Rankin is a freelance medical writer.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025